LOINC Code 104132-6: HPV 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA NAA+probe (Cvx) [Interp]
104132-6 is a LOINC code used to identify HPV 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA NAA+probe (Cvx) [Interp] in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Human papilloma virus 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNA. It is commonly used with the system or sample type Cvx.
What is this code?
LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Human papilloma virus 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNA. It is commonly used with the system or sample type Cvx.
When is it used?
- Used in lab systems, EHRs, and clinical data exchange.
- May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
- Status: ACTIVE
- Order vs observation: Observation
- Method: Probe.amp.tar
What it does not mean
- The code identifies the observation or test, not the actual result.
Key facts
- Human papilloma virus 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA [Interpretation] in Cervix by NAA with probe detection
- Human papilloma virus 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNA
- This term was created for, but not limited in use to, the Alinity High Risk HPV test kit which detects 14 HR HPV genotypes (HPV 16, 18, 31, 33, 35, 39, 45,51, 52, 56, 58, 59, 66, and 68) is achieved through a primer mix targeting a conserved region of the HPV genomes and single stranded DNA probes. This test identifies high-risk (HR) HPV types 16, 18, 45, while reporting the concurrent detection of the other HR genotypes (31/33/52/58) and (35/39/51/56/59/66/68). This test is indicated for use in routine cervical cancer screening.
- 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HPV; HPV 16 & 18+45; HPV 16+18+45+31 H Risk 14 DNA; HPV16; HPV16 and 18; HPV16+18; HPV16+18+H Risk 14; Human papillomavirus; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification
Where you may see this code
You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.